AUBURN UNIVERSITY—An Auburn University research team has produced a new drug candidate that could one day slow or even stop the deadly Ebola virus. The discovery will be published in an upcoming issue of the journal Bioorganic and Medicinal Chemistry.
The group, led by professor of chemistry and biochemistry Stewart Schneller, has designed a compound aimed at reversing the immune-blocking abilities of certain viruses, including Ebola.
“In simple terms, the Ebola virus has the ability to turn off the body’s natural immune response,” Schneller said. “We have made a small tweak in compound structure that will turn that response back on.”